Stocklytics Platform
Asset logo for symbol SNDX
Syndax Pharmaceuticals
SNDX52
$14.92arrow_drop_down1.06%-$0.16
Asset logo for symbol SNDX
SNDX52

$14.92

arrow_drop_down1.06%
Key Stats
Open$15.19
Prev. Close$15.08
EPS-3.64
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range14.79
15.39
52 Week Range11.21
25.34
Ratios
Revenue-
EBITDA Margin %-
EPS-3.64
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.98%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

SNDX-
US Healthcare Sector-
US Market-
warning

SNDX / Market

SNDX lose to the US Market which returned -0.15% over the last twenty four hours.
warning

SNDX / Healthcare Sector

SNDX lose to the US Healthcare sector which returned 1.08% over the last twenty four hours.

Syndax Pharmaceuticals (SNDX) Statistics

Syndax Pharmaceuticals Inc (SNDX) is a biopharmaceutical company that focuses on developing and commercializing therapies for the treatment of cancer and other diseases. The company's valuation metrics indicate its market worth and potential for growth. SNDX's valuation metrics include its market capitalization, enterprise value, and price-to-earnings ratio. These metrics help investors evaluate the company's worth and compare it to other companies in the same sector.
SNDX's fundamentals are also important to consider when assessing its investment potential. The company's fundamentals include its financial performance, such as revenue per share, profit margin, total debt, and gross profit. These fundamentals provide insights into SNDX's operational efficiency, profitability, and financial health. For example, a high revenue per share indicates strong sales growth, while a low profit margin may suggest cost management issues.
add Syndax Pharmaceuticals  to watchlist

Keep an eye on Syndax Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Syndax Pharmaceuticals (SNDX) stock's performance compared to its sector and the market over the past year?

Over the past year, Syndax Pharmaceuticals (SNDX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 17.81%, Syndax Pharmaceuticals has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 38.31%, it has fallen short of the market average. This comparison highlights Syndax Pharmaceuticals 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Syndax Pharmaceuticals (SNDX) stock?

The PE ratio for Syndax Pharmaceuticals (SNDX) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Syndax Pharmaceuticals (SNDX) stock?

The Earnings Per Share (EPS) for Syndax Pharmaceuticals (SNDX), calculated on a diluted basis, is -$3.64. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Syndax Pharmaceuticals (SNDX) stock?

The operating margin for Syndax Pharmaceuticals (SNDX) is -716.62%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Syndax Pharmaceuticals (SNDX) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Syndax Pharmaceuticals (SNDX) is -$321.2M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Syndax Pharmaceuticals (SNDX) have?

Syndax Pharmaceuticals (SNDX) has a total debt of $854K. The net debt, which accounts for cash and cash equivalents against the total debt, is -$132.16M.

Take Your Investments to a Whole New Level